The award will be presented Oct. 10 during the American Heart Association’s Hypertension Scientific Session in Arlington, Virginia.

Vanderbilt Health researchers developed a natural language processing tool that can efficiently identify patients with liver disease and streamline assessment for treatments.

Researchers showed that blocking the protein cadherin-11 improved survival and kidney function in three kidney injury models.

Vanderbilt Technologies for Advanced Genomics is a one-stop genomics research resource that offers sample biobanking, genome sequencing, single-cell and spatial multiomic profiling, and other specialized services.

Study provides a unique resource to guide future research on acute rejection diagnosis, therapeutic response prediction, and risk for chronic rejection.

Muñoz has served as a member of the AHA’s Greater Nashville Board, including a two-year term as president from 2021-2023.

Patients who qualify for new Alzheimer's disease therapies often wait weeks before receiving a first infusion.